权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Live-cell Activity Architecture in Cancer

癌症中的活细胞活性结构

基本信息

批准号：
10673027
负责人：
Jin Zhang
金额：
$ 92.9万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-08-01 至 2029-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10673027
关键词：
Apoptosis Architecture Automobile Driving Biochemical Biochemistry Biological Assay Biosensor Buffers Cell Proliferation Cells Cessation of life Cyclic AMP Cyclic AMP-Dependent Protein Kinases Development Fibrolamellar Hepatocellular Carcinoma Goals Image Imaging technology Laboratories Length Liquid substance Malignant Neoplasms Malignant neoplasm of pancreas Measures Molecular Mus Oncogenic Pathway interactions Peer Review Phase Phosphotransferases Physical condensation Physiological Protein Subunits Publishing Ras Inhibitor Regulation Research Research Support Second Messenger Systems Signal Transduction Signaling Molecule Suicide Technology Therapeutic anticancer research awake cancer cell cell growth cell growth regulation cell transformation high resolution imaging innovative technologies novel novel therapeutics programs protein protein interaction spatiotemporal tumor growth tumorigenesis ultra high resolution uncontrolled cell growth

项目摘要

Project summary: Essential regulation of the cellular machinery is achieved by a network of highly dynamic signaling molecules, which, when dysregulated, allow cancer cells to misinterpret or ignore signals that normally tell cells to stop dividing or begin apoptosis, leading to uncontrolled tumor growth. For the last 18 years, my laboratory has been at the forefront of applying a native biochemistry approach to cell signaling and cancer research. We have developed enabling technologies, and established spatiotemporal regulation as a fundamental paradigm in cell signaling, and discovered that its alteration leads to uncontrolled cell growth. This NCI R35-supported research program seeks to establish a new conceptual framework to specifically understand the cellular organization of molecular activities. We hypothesize that cellular biochemical activities are spatially organized into an “activity architecture” and dysregulated driver molecules can re-organize and re-structure this activity architecture, leading to loss of control over cell growth, division and death. In the past 6 years, we published 51 peer-reviewed articles, and made significant advances in establishing this framework. We developed first-in-class technologies for imaging protein-protein interactions and enzymatic activities in living cells at molecular length-scales and first kinase biosensor that achieved high- resolution imaging in awake mice, which have provided evidence for the biochemical activity architecture across different scales. We also made a breakthrough discovery that a regulatory subunit of Protein Kinase A (PKA), RIα, undergoes liquid-liquid phase-separation (LLPS) to enable the dynamic buffering and spatial compartmentalization of a ubiquitous second messenger, cAMP, providing an answer to a long standing question. We further showed that the oncogenic fusion in fibrolamellar carcinoma (FLC) potently inhibits RIα LLPS and induces aberrant cAMP signaling, which leads to increased cell proliferation and cell transformation. We have also discovered novel regulation in the Ras/ERK pathway and developed a novel Ras biosensor. In the proposed research, we will have three focuses. First, we will develop innovative technologies including super-resolution activity imaging to illuminate the biochemical activity architecture across different scales. Secondly, we will elucidate how the disorganized cAMP-PKA activity architecture leads to tumorigenesis in FLC, and further discover novel, cancer-relevant biomolecular condensates. Thirdly, we will investigate the spatiotemporal regulation of ERK that is critical for its physiological functions and identify the vulnerable connections in the re-organized cancer-driving architecture in pancreatic cancer, which is a deadly cancer that is addicted to the Ras-ERK pathway. We will also facilitate the development of new therapeutics by developing novel assays for evaluating Ras inhibitors and measuring target engagement.

项目总结:

项目成果

期刊论文数量（27）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

An ultrasensitive biosensor for high-resolution kinase activity imaging in awake mice.

DOI：
10.1038/s41589-020-00660-y
发表时间：
2021-01
期刊：
Nature chemical biology
影响因子：
14.8
作者：
Zhang JF;Liu B;Hong I;Mo A;Roth RH;Tenner B;Lin W;Zhang JZ;Molina RS;Drobizhev M;Hughes TE;Tian L;Huganir RL;Mehta S;Zhang J
通讯作者：
Zhang J

Fourier Optical Spin Splitting Microscopy.

DOI：
10.1103/physrevlett.129.020801
发表时间：
2022-07
期刊：
Physical review letters
影响因子：
8.6
作者：
Junxiao Zhou;Qianyi Wu;Junxiang Zhao;Clara Posner;M. Lei;Guanghao Chen;Jin Zhang;Zhaowei Liu
通讯作者：
Junxiao Zhou;Qianyi Wu;Junxiang Zhao;Clara Posner;M. Lei;Guanghao Chen;Jin Zhang;Zhaowei Liu

Observing the Assembly of Protein Complexes in Living Eukaryotic Cells in Super-Resolution Using refSOFI.

使用 refSOFI 在超分辨率下观察活体真核细胞中蛋白质复合物的组装。